Cargando…
Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
Autores principales: | de Chaisemartin, Luc, Diep, Antoine, Gonnin, Cécile, Soria, Angèle, Barbaud, Annick, Nicaise-Roland, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863137/ https://www.ncbi.nlm.nih.gov/pubmed/35216744 http://dx.doi.org/10.1016/j.anai.2021.11.012 |
Ejemplares similares
-
Immediate hypersensitivity to COVID-19 vaccines: Focus on biological diagnosis
por: Nicaise-Roland, Pascale, et al.
Publicado: (2022) -
Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022) -
Higher basal tryptase, asthma and loss of consciousness in anaphylaxis are associated with biphasic reactions
por: Langlois, Terence, et al.
Publicado: (2022) -
Retour d’expérience sur la vaccination anti-Covid-19 des patients étiquetés « à risque allergique »
por: Castagna, Julie, et al.
Publicado: (2021) -
Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
por: Pitlick, Mitchell M., et al.
Publicado: (2021)